Dr. Brian W. Loggie
As one of the pioneers of heated intraperitoneal chemotherapy, Dr. Brian W. Loggie is known for stepping out of the box when it comes to mesothelioma treatment. Today, the procedure, commonly referred to as Hyperthermic Intraperitoneal Chemotherapy or HIPEC, has changed the face of peritoneal mesothelioma treatment and the treatment of other abdominal cancers.
Loggie is the chief of the division of surgical oncology and the director of the Cancer Biology Program at the Creighton University School of Medicine in Omaha, Nebraska. Loggie has an international reputation for expertise in treating peritoneal mesothelioma. Patients travel from across the nation to see him. He believes in aggressive treatment but also preserving the patient’s quality of life. Loggie is known as a caring physician who places special emphasis on his patients.
Connect with Top Doctors and Cancer Centers
Get help connecting with a mesothelioma doctor or treatment center near you right now!
Mesothelioma Specialist in Nebraska
Even though Nebraska has no known naturally occurring asbestos deposits, manufacturers and industries have shipped in this dangerous mineral by the truckload. Asbestos, which is the most common source of mesothelioma, was widely used at power-generation plants, petroleum plants and vermiculite plants.
If you or a loved one has been diagnosed with mesothelioma and are in need of a mesothelioma specialist, contact us today. Our Patient Advocates can help you get a quick appointment so you can discuss treatment options with a doctor.
What are Loggie's specialties
Loggie specializes in treating peritoneal cancers, including mesothelioma. He is part of a team that is focusing on malignant peritoneal mesothelioma by reviewing the tumor’s microenvironment, signaling pathways, tumor models and inflammation.
Loggie was among the first surgeons in the country to use the HIPEC procedure. Since that 1992 procedure, Loggie has undertaken extensive research into the treatment of peritoneal mesothelioma. Some of these studies are regarding the HIPEC procedure using the drug Carboplatin. He said HIPEC along with cytoreductive surgery is a viable option for some peritoneal mesothelioma patients. He believes the treatment helps some patients live longer and have a better quality of life.
Loggie is known as a physician who has a passion for helping. In 2010, Loggie led a team of physicians and nurses to Haiti following the earthquake that devastated the island nation. They worked for 11 days to help some of the most injured patients.
What is Loggie’s background
Loggie received his medical degree and finished postgraduate training at McGill University in Montreal, Canada. He went on for specialized training at the University of Illinois and the Royal College of Physician and Surgeons in Canada.
Loggie has held faculty positions at the University of Illinois, Bowman Gray School of Medicine in North Carolina and the University of Texas. He was formerly the director of the Mesothelioma Applied Research Foundation (MARF).
Upon arriving at Creighton University School, he founded the school’s division of surgical oncology.
Creighton University School of Medicine. Loggie, Brian W. MD, CM. FRCSC, FACS. Retrieved from http://medschool.creighton.edu/somfaculty/loggie/contact/